JNJ

Johnson & Johnson

Halal Rating :
Comfortable
Last Price $144.45 Last updated:
Market Cap $373.21b
7D Change -1.48%
1 Year Change -6.71%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 15, 2024

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 29, 2024 $22.47b $17.63b - $193.0m 0.00% 1.09%
June 30, 2024 $22.45b $16.44b - $270.0m 0.00% 1.64%
March 31, 2024 $21.38b $15.63b - $155.0m 0.00% 0.99%

Company Impact

Help us evaluate Johnson & Johnson's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates